NuGen Medical Devices Inc.
NGMD.V
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -80.34% | -72.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -80.34% | -72.59% | |||
| Cost of Revenue | -82.42% | -73.29% | |||
| Gross Profit | -78.67% | -72.00% | |||
| SG&A Expenses | 16.96% | -22.06% | |||
| Depreciation & Amortization | 7.83% | -2.83% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.02% | -27.28% | |||
| Operating Income | -22.60% | 5.60% | |||
| Income Before Tax | -253.54% | 202.35% | |||
| Income Tax Expenses | 11.11% | 196.43% | |||
| Earnings from Continuing Operations | -254.19% | 199.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -254.19% | 199.29% | |||
| EBIT | -22.60% | 5.60% | |||
| EBITDA | -26.01% | 6.21% | |||
| EPS Basic | -254.17% | 182.35% | |||
| Normalized Basic EPS | -253.33% | 314.29% | |||
| EPS Diluted | -254.17% | 182.35% | |||
| Normalized Diluted EPS | -253.33% | 314.29% | |||
| Average Basic Shares Outstanding | 0.25% | 3.20% | |||
| Average Diluted Shares Outstanding | 0.25% | 3.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||